Search Results

There are 12638 results for: content related to: Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma

  1. You have free access to this content
    Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma


    Volume 120, Issue 5, 1 March 2014, Pages: 692–701, Petros D. Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler, Robert Dreicer, Manish Kohli, Daniel P. Petrylak, David J. Vaughn, Kathryn A. Bylow, Steven G. Wong, Joseph L. Sottnik, Evan T. Keller, Mahmoud Al-Hawary, David C. Smith and Maha Hussain

    Version of Record online : 18 NOV 2013, DOI: 10.1002/cncr.28477

  2. You have free access to this content
    Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment-use trial of sunitinib


    Volume 121, Issue 9, May 1, 2015, Pages: 1405–1413, Peter Reichardt, Yoon-Koo Kang, Piotr Rutkowski, Jochen Schuette, Lee S. Rosen, Beatrice Seddon, Suayib Yalcin, Hans Gelderblom, Charles C. Williams Jr, Elena Fumagalli, Guido Biasco, Herbert I. Hurwitz, Pamela E. Kaiser, Kolette Fly, Ewa Matczak, Liang Chen, Maria José Lechuga and George D. Demetri

    Version of Record online : 13 JAN 2015, DOI: 10.1002/cncr.29220

  3. You have free access to this content
    A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061


    Volume 120, Issue 8, 15 April 2014, Pages: 1194–1202, Michelle A. Rudek, Page C. Moore, Ronald T. Mitsuyasu, Bruce J. Dezube, David Aboulafia, John Gerecitano, Ryan Sullivan, Mary E. Cianfrocca, David H. Henry, Lee Ratner, Missak Haigentz, Afshin Dowlati, Richard F. Little, Susan Percy Ivy and John F. Deeken

    Version of Record online : 28 JAN 2014, DOI: 10.1002/cncr.28554

  4. You have free access to this content
    Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway


    Volume 121, Issue 2, January 15, 2015, Pages: 311–319, Ole-Petter R. Hamnvik, Toni K. Choueiri, Alexander Turchin, Rana R. McKay, Lipika Goyal, Michael Davis, Marina D. Kaymakcalan and Jonathan S. Williams

    Version of Record online : 18 SEP 2014, DOI: 10.1002/cncr.28972

  5. You have free access to this content
    Medical management of metastatic medullary thyroid cancer


    Volume 120, Issue 21, November 1, 2014, Pages: 3287–3301, Jessica E. Maxwell, Scott K. Sherman, Thomas M. O'Dorisio and James R. Howe

    Version of Record online : 18 JUN 2014, DOI: 10.1002/cncr.28858

  6. You have free access to this content
    Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma


    Volume 121, Issue 22, November 15, 2015, Pages: 4007–4015, Elizabeth I. Buchbinder, Jeffrey A. Sosman, Donald P. Lawrence, David F. McDermott, Nikhil H. Ramaiya, Annick D. Van den Abbeele, Gerald P. Linette, Anita Giobbie-Hurder and F. Stephen Hodi

    Version of Record online : 11 AUG 2015, DOI: 10.1002/cncr.29622

  7. You have free access to this content
    Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma


    Volume 122, Issue 1, January 1, 2016, Pages: 124–130, Sekwon Jang, Chaoyi Zheng, Huei-Ting Tsai, Alex Z. Fu, Ana Barac, Michael B. Atkins, Andrew N. Freedman, Lori Minasian and Arnold L. Potosky

    Version of Record online : 6 OCT 2015, DOI: 10.1002/cncr.29728

  8. Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma


    Volume 122, Issue 7, April 1, 2016, Pages: 1108–1115, Jennifer L. Beaumont, John M. Salsman, Jose Diaz, Keith C. Deen, Lauren McCann, Thomas Powles, Michelle D. Hackshaw, Robert J. Motzer and David Cella

    Version of Record online : 27 JAN 2016, DOI: 10.1002/cncr.29888

  9. You have free access to this content
    Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy

    International Journal of Cancer

    Volume 130, Issue 8, 15 April 2012, Pages: 1948–1959, Benedetto Farsaci, Jack P. Higgins and James W. Hodge

    Version of Record online : 8 AUG 2011, DOI: 10.1002/ijc.26219

  10. You have full text access to this OnlineOpen article
    Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment

    Cancer Science

    Volume 106, Issue 2, February 2015, Pages: 160–170, Gökçe Hatipoglu, Stefan W. Hock, Ruth Weiss, Zheng Fan, Tina Sehm, Ali Ghoochani, Michael Buchfelder, Nicolai E. Savaskan and Ilker Y. Eyüpoglu

    Version of Record online : 15 FEB 2015, DOI: 10.1111/cas.12580

  11. You have free access to this content
    Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date


    Volume 121, Issue 4, February 15, 2015, Pages: 502–516, Jayson I. L. Bastien, Katharine A. McNeill and Howard A. Fine

    Version of Record online : 23 SEP 2014, DOI: 10.1002/cncr.28968

  12. You have free access to this content
    Management of sunitinib adverse events in renal cell carcinoma patients: The Asian experience

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 132–144, Aiping ZHOU

    Version of Record online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01525.x

  13. You have free access to this content
    Therapeutic strategies for neuroendocrine liver metastases


    Volume 121, Issue 8, April 15, 2015, Pages: 1172–1186, Andrea Frilling and Ashley K. Clift

    Version of Record online : 1 OCT 2014, DOI: 10.1002/cncr.28760

  14. You have free access to this content
    Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma


    Volume 121, Issue 19, October 1, 2015, Pages: 3435–3443, M. Dror Michaelson, Rana R. McKay, Lillian Werner, Michael B. Atkins, Eliezer M. Van Allen, Kara M. Olivier, Jiaxi Song, Sabina Signoretti, David F. McDermott and Toni K. Choueiri

    Version of Record online : 8 JUN 2015, DOI: 10.1002/cncr.29503

  15. You have full text access to this OnlineOpen article
    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 430–441, Eva Juengel, Dana Kim, Jasmina Makarević, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp and Roman A. Blaheta

    Version of Record online : 2 DEC 2014, DOI: 10.1111/jcmm.12471

  16. You have full text access to this OnlineOpen article
    Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction

    Cancer Medicine

    Volume 4, Issue 7, July 2015, Pages: 1003–1015, Esther A. Kleibeuker, Matthijs A. ten Hooven, Kitty C. Castricum, Richard Honeywell, Arjan W. Griffioen, Henk M. Verheul, Ben J. Slotman and Victor L. Thijssen

    Version of Record online : 31 MAR 2015, DOI: 10.1002/cam4.441

  17. You have free access to this content
    Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 809–819, Huixin Yu, Neeltje Steeghs, Jacqueline S. L. Kloth, Djoeke de Wit, J. G. Coen van Hasselt, Nielka P. van Erp, Jos H. Beijnen, Jan H. M. Schellens, Ron H. J. Mathijssen and Alwin D. R. Huitema

    Version of Record online : 22 APR 2015, DOI: 10.1111/bcp.12550

  18. You have free access to this content
    Treating advanced hepatocellular carcinoma: How to get out of first gear


    Volume 120, Issue 20, October 15, 2014, Pages: 3122–3130, James J. Harding and Ghassan K. Abou-Alfa

    Version of Record online : 4 JUN 2014, DOI: 10.1002/cncr.28850

  19. Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells

    The Prostate

    Volume 75, Issue 11, August 1, 2015, Pages: 1137–1149, Roque Diaz, Paul A. Nguewa, Miriam Redrado, Irene Manrique and Alfonso Calvo

    Version of Record online : 20 APR 2015, DOI: 10.1002/pros.22980

  20. You have free access to this content
    A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy


    Volume 120, Issue 11, 1 June 2014, Pages: 1647–1655, Jorge A. Garcia, Gary R. Hudes, Toni K. Choueiri, Walter M. Stadler, Laura S. Wood, Jayne Gurtler, Shailender Bhatia, Adarsh Joshi, Rebecca R. Hozak, Yihuan Xu, Jonathan D. Schwartz and John A. Thompson

    Version of Record online : 27 FEB 2014, DOI: 10.1002/cncr.28634